Nosopharm
Nîmes
About Nosopharm
Nosopharm is a young innovative biotechnology company dedicated to anti-infective drug discovery. Nosopharm addresses the unmet medical need of the bacterial multidrug resistance to antibiotics, a very concerning issue for hospital-acquired infections. Nosopharm has set up an innovative anti-infective drug discovery platform based on the medicinal mining of the microbial biodiversity. The company has developed a unique expertise in the screening and the characterization of bioactive secondary metabolites produced by an original microbial bioresource: the bacterial genera Xenorhabdus and Photorhabdus.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Last round: Debt Financing (Feb 2018)
- Website: nosopharm.com
- Phone: +330466265321
Industries & Categories
Biotechnology, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/nosopharm-168999 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.